Insider · CIK 0001485508

Collins Cooper C.

CIK 0001485508 Name as filed on the most recent filing

Filed as Collins Cooper C. (20)

39 transaction lines · from 20 filings · filed 2011-07-25 to 2024-08-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

39 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-08-22 P, Open-market purchase TherapeuticsMD, Inc.TXMD 7,099, acquired Open Form 4 filing 0000905148-24-002363
2024-08-21 P, Open-market purchase TherapeuticsMD, Inc.TXMD 2,039, acquired Open Form 4 filing 0000905148-24-002340
2021-11-18 P, Open-market purchase TherapeuticsMD, Inc.TXMD 578,500, acquired Open Form 4 filing 0001209191-21-066002
2021-08-18 P, Open-market purchase TherapeuticsMD, Inc.TXMD 648,000, acquired Open Form 4 filing 0001387131-21-008733
2021-08-17 P, Open-market purchase TherapeuticsMD, Inc.TXMD 77,000, acquired Open Form 4 filing 0001387131-21-008733
2020-06-09 P, Open-market purchase TherapeuticsMD, Inc.TXMD 68,875, acquired Open Form 4 filing 0001387131-20-005591
2020-06-08 P, Open-market purchase TherapeuticsMD, Inc.TXMD 38,425, acquired Open Form 4 filing 0001387131-20-005591
2019-05-13 P, Open-market purchase TherapeuticsMD, Inc.TXMD 99,870, acquired Open Form 4 filing 0001387131-19-003731
2016-03-11 P, Open-market purchase TherapeuticsMD, Inc.TXMD 99,717, acquired Open Form 4 filing 0001387131-16-004575
2014-06-05 P, Open-market purchase TherapeuticsMD, Inc.TXMD 76,890, acquired Open Form 4 filing 0001387131-14-002173
2014-04-02 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 124,131, disposed Open Form 4 filing 0001354488-14-001654
2014-04-01 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 348,952, disposed Open Form 4 filing 0001354488-14-001654
2014-03-04 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 2 lines 12,069,222, disposed Open Form 4 filing 0001354488-14-001012
2014-03-03 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 154,547, disposed Open Form 4 filing 0001354488-14-001012
2014-02-05 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 2 lines 39,619, disposed Open Form 4 filing 0001354488-14-000509
2014-02-04 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 89,582, disposed Open Form 4 filing 0001354488-14-000509
2014-02-03 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 70,524, disposed Open Form 4 filing 0001354488-14-000509
2014-01-07 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 61,611, disposed Open Form 4 filing 0001354488-14-000098
2014-01-06 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 63,445, disposed Open Form 4 filing 0001354488-14-000060
2014-01-03 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 14,983, disposed Open Form 4 filing 0001354488-14-000060
2014-01-02 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 67,286, disposed Open Form 4 filing 0001354488-14-000060
2013-12-06 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 40,114, disposed Open Form 4 filing 0001354488-13-006781
2013-12-05 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 46,514, disposed Open Form 4 filing 0001354488-13-006781
2013-12-04 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 73,900, disposed Open Form 4 filing 0001354488-13-006714
2013-12-03 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 18,422, disposed Open Form 4 filing 0001354488-13-006714
2013-12-02 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 35,890, disposed Open Form 4 filing 0001354488-13-006714
2013-11-05 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 60,254, disposed Open Form 4 filing 0001354488-13-006005
2013-11-04 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 30,620, disposed Open Form 4 filing 0001354488-13-006005
2013-11-01 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 89,732, disposed Open Form 4 filing 0001354488-13-006005
2013-10-08 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 502, disposed Open Form 4 filing 0001354488-13-005587
2013-10-07 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 30,780, disposed Open Form 4 filing 0001354488-13-005587
2013-10-04 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 26,443, disposed Open Form 4 filing 0001354488-13-005587
2013-10-03 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 63,312, disposed Open Form 4 filing 0001354488-13-005551
2013-10-02 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 33,909, disposed Open Form 4 filing 0001354488-13-005551
2013-10-01 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 72,516, disposed Open Form 4 filing 0001354488-13-005551
2013-06-14 S, Open-market sale TherapeuticsMD, Inc.TXMD 4,605,263, disposed Open Form 4 filing 0001387131-13-002242
2011-07-21 S, Open-market sale Pernix Therapeutics Holdings, Inc.PTX 3,489,003, disposed Open Form 4 filing 0001354488-11-002326

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 29
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Collins Cooper C., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001485508

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.